Higher use seen among males, White people, and those from higher socioeconomic backgrounds
Findings for older patients presenting to emergency department with transient ischemic attack
VLA1553 induced seroprotective chikungunya virus neutralizing antibody levels in 98.9 percent of those receiving vaccine